Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium

Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium

Abstract: Progression of disease within 24 months of initial immunochemotherapy (POD24) is a negative prognostic factor for patients with follicular lymphoma (FL). There is no standard treatment after POD24. Assembling an academic-based cohort from the Lymphoma Epidemiology of Outcomes Consortium fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Jonathan R. Day, Melissa C. Larson, Urshila Durani, Jean L. Koff, Yucai Wang, Thomas M. Habermann, Izidore S. Lossos, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B. Cohen, Brad S. Kahl, Jia Ruan, W. Richard Burack, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer, Carla Casulo
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952924006773
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2473952924006773

Similar Items